View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

David Carlson ... (+8)
  • David Carlson
  • David Nierengarten
  • Dennis Pak
  • Laura Chico
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Sam Ravina
Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: May 16, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Comfort Systems Usa Inc: 1 director

A director at Comfort Systems Usa Inc gave away/sold 1,597 shares at 0.000USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

 PRESS RELEASE

CVRx Announces Key Senior Leadership Team Hires

CVRx Announces Key Senior Leadership Team Hires Dr. Philip B. Adamson will join as Chief Medical OfficerBonnie Handke will join as Senior Vice President of Patient Access, Reimbursement, and Healthcare EconomicsJennifer E. Englund joins as Senior Vice President of Global Clinical Affairs MINNEAPOLIS, May 16, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced three additions to its senior leadership team. Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) has been appointed as Chief Medical Officer, Bonnie Handke, RN, MBA...

 PRESS RELEASE

Lantronix to Display New Cloud Software Platform and Telematic Tracker...

Lantronix to Display New Cloud Software Platform and Telematic Trackers at IoT Solutions World Congress Lantronix Also to Preview Its New Tracx Browser-Based Fleet Management Hub IRVINE, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions, today announced that its innovative Cloud Software Platform and new and edge compute telematic trackers will debut at the upcoming IoT Solutions World Congress from May 21–23, 2024, at Barcelona’s Gran Via Venue. Lantronix will also preview its upcoming centralized, browser-based hub ...

Crocs Inc: 1 director

A director at Crocs Inc sold 10,174 shares at 140.316USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Chevron Corp: 1 director

A director at Chevron Corp sold 2,549 shares at 165.244USD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

 PRESS RELEASE

Aerovate Therapeutics Announces First Quarter Financial Results and Bu...

Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial hypertension (PAH) Enrollment continues into the Phase 3 portion of the IMPAHCT trial of AV-101  Poster to be presented with baseline characteristics of the Phase 2b portion of the IMPAHCT trial at the ATS 2024 Conference on May 21  Cash runway into 2026, based on our current operating plan   WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeuti...

 PRESS RELEASE

Enovix Begins Customer Sampling of EX-1M Batteries

Enovix Begins Customer Sampling of EX-1M Batteries FREMONT, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced that it has begun customer sampling of its breakthrough EX-1M battery. Initial EX-1M samples were built and tested at the company’s facility in Fremont for IoT and smartphone customers. Enovix plans to build a larger number of EX-1M samples from its Agility Line at Fab2 in Malaysia later in the second quarter of 2024. “We set out on an ambitious plan last year to build a battery that would meet the dem...

 PRESS RELEASE

Lantronix Inc. Appoints Mathi Gurusamy as Chief Strategy Officer to Dr...

Lantronix Inc. Appoints Mathi Gurusamy as Chief Strategy Officer to Drive Strategic Growth and Build Market Leadership IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: LTRX), a global provider of compute and connectivity IoT solutions, today announced the appointment of Mathi Gurusamy as its chief strategy officer (CSO), effective May 13, 2024. In his new role, Gurusamy will spearhead the company’s strategic planning and execution of growth opportunities, manage merger and acquisition activities, and drive go-to-market strategies that address key IoT technology trends to bolster...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch